Identification and Testing of HBII-52 and HBII85 snoRNA Molecules as Potential Therapy for Prader Willi Syndrome

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/1012/31/12

Funding

  • Shire Human Genetic Therapies Incorporated: $227,925.00